Biblio
Export 1191 results:
Author [ Title
Filters: First Letter Of Last Name is D [Clear All Filters]
“Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.”, J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
, “Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 303-15, 2016.
, “Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study.”, J Alzheimers Dis, vol. 62, no. 1, pp. 93-97, 2018.
, “A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
, “Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 731-746, 2018.
, “Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.”, J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
, “A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 679-692, 2022.
, “Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 707-16, 2016.
, “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
, “Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.”, J Alzheimers Dis, vol. 63, no. 1, pp. 115-130, 2018.
, “Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice.”, J Alzheimers Dis, vol. 63, no. 1, pp. 115-130, 2018.
, “Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1215-1222, 2017.
, “Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.”, J Alzheimers Dis, vol. 77, no. 1, pp. 275-290, 2020.
, “Is Computerized Working Memory Training Effective in Healthy Older Adults? Evidence from a Multi-Site, Randomized Controlled Trial.”, J Alzheimers Dis, vol. 65, no. 3, pp. 931-949, 2018.
, “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
, “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
, “The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1005-1015, 2020.
, “Copy Number Variants in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 37-52, 2017.
, “Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.”, J Alzheimers Dis, vol. 52, no. 3, pp. 849-61, 2016.
, “Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 415-428, 2017.
, “Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.”, J Alzheimers Dis, 2015.
, “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
, “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
, “Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
,